EHZ Peptides
EHZ Peptides' purity-focused record is led by Retatrutide and mostly solid Tirzepatide, with recent tests showing recovered identity, purity, and fill after earlier misses. Weakness is dispersed into BPC-157 purity/underfill failures and a GHK-Cu identity failure; evidence is recent but batch identifiers are often absent, limiting traceability.
The investigation follows a WhatsApp-first seller with an unregistered obvious domain, no Delaware entity, and a gated PepChat lead. It also documents batch-ID gaps, brand-confusion risk, and a clean public affiliate scan with closed channels unresolved.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including EHZ Peptides rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 21 Jul 2026 | Fail | Tesamorelin EHZ Peptides | lab name | View COA | |||
| 17 Jul 2026 | Pass | Retatrutide EHZ Peptides | lab name | View COA | |||
| 13 Jul 2026 | Fail | Tesamorelin EHZ Peptides | lab name | View COA | |||
| 13 Jul 2026 | Pass | GHK-Cu EHZ Peptides | lab name | View COA | |||
| 13 Jul 2026 | Pass | Retatrutide EHZ Peptides | lab name | View COA | |||
| 13 Jul 2026 | Fail | BPC-157 EHZ Peptides | lab name | View COA | |||
| 16 Jun 2026 | Pass | Retatrutide EHZ Peptides | lab name | View COA | |||
| 28 Apr 2026 | Pass | Tirzepatide EHZ Peptides | lab name | View COA | |||
| 6 Mar 2026 | Pass | GHK-Cu EHZ Peptides | lab name | View COA | |||
| 6 Mar 2026 | Pass | GHK-Cu EHZ Peptides | lab name | View COA | |||
About EHZ Peptides test results from Finnrick
EHZ Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 60 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible EHZ Peptides peptides in this dataset are Retatrutide (29 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 60 recent tests.